Cancer

Article	Citations
Indeterminate pulmonary nodules in non‐rhabdomyosarcoma soft tissue sarcoma: A study of the European paediatric Soft Tissue Sarcoma Study Group	1320
Conception and pregnancy among women with a live birth after breast cancer treatment: A survey study of young breast cancer survivors	227
Issue Information	177
A local perspective on internal, external, and reflexive biomarker testing processes for lung cancer in an academic medical center	156
Modeled residual current cancer risk after clinical investigation of a positive multicancer early detection test result	127
Impact of TAILORx on chemotherapy prescribing and 21‐gene recurrence score–guided treatment costs in a population‐based cohort of patients with breast cancer	106
Issue Information	105
Impact of smoking status on engagement in remote symptom monitoring after oncologic surgery: Implications for symptom management and readmission rates	102
Measuring the impact of a catchment area surveillance tool on cancer center adopters	98
Impact of obesity on outcome in children diagnosed with cancer in Canada: A report from Cancer in Young People in Canada	97
Pathogenic germline variants in patients with endometrial cancer of diverse ancestry	92
	91
Dietary supplement use among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study	88
Effect of a 1‐year physical activity intervention on quality of life, fatigue, and distress in adult childhood cancer survivors—A randomized controlled trial (SURfit)	86
Annual report to the nation on the status of cancer, part 1: National cancer statistics	85
An updated assessment of 43,110 patients enrolled in the Childhood Cancer Research Network: A Children's Oncology Group report	74
First phase 1 clinical study of olaparib in pediatric patients with refractory solid tumors	63
Incidence, risk factors, and management of alpelisib‐associated hyperglycemia in metastatic breast cancer	63
Prognostic impact of lymph node involvement and loss of heterozygosity of 1p or 16q in stage III favorable histology Wilms tumor: A report from Children’s Oncology Group Studies AREN03B2 and AREN0532	62
Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study	56
Soft tissue sarcoma incidences and clinical characteristics are significantly different in France and Taiwan	55
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study	55
Risk of suicide among individuals with a history of childhood cancer	53
Risk model‐based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model	53
Effect of an mHealth intervention on physical activity outcomes among young adult cancer survivors: The IMPACT randomized controlled trial	52

Oncology patients' perception of physicians who use an integrated electronic health record (EHR) during clinic visits: PRIME‐EHR double‐blind, randomized controlled trial	50
Reply to “Empathic communication: The premise of inclusive care for historically excluded populations”	47
Intersecting identities and cancer screening	46
Issue Information	45
Pediatric inflammatory bowel disease increases cancer risk	45
Issue Information	44
Evaluating educational interventions to increase breast density awareness among Latinas: A randomized trial in a Federally Qualified Health Center	44
Management recommendations for pancreatic manifestations of von Hippel–Lindau disease	44
Epigenetic age acceleration, fatigue, and inflammation in patients undergoing radiation therapy for head and neck cancer: A longitudinal study	44
Lower risk of depression after smoking cessation and alcohol abstinence in patients with gastric cancer who underwent gastrectomy: A population‐based, nationwide cohort study	43
More social determinants lead to more cancer death: A tragic dose response	43
Altering the microbiome for immunotherapy‐resistant urological tumors—An intriguing but still early concept	42
	41
Risk‐adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study	41
First person profile: Mary‐Ellen Taplin, MD	40
New standard of care for multiple myeloma?	40
Neurologic complications of breast cancer	40
Issue Information	40
MRI‐guided radiotherapy results in fewer toxicities for localized prostate cancer	39
Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?	39
Talazoparib for newly diagnosed prostate cancer associated with significant risk reduction of disease progression	39
Issue Information	38
Reply to COVID‐19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors	38
	38
What is a good medical choice?	38
Issue Information	38
First person profile: Richard Pazdur, MD	37
Racism and health among cancer survivors	37
Stopping immunotherapy after 2 years is practical in patients with advanced non–small cell lung cancer	37
Temporal changes in the probability of live birth among female survivors of childhood cancer: A population‐based Adult Life After Childhood Cancer in Scandinavia (ALiCCS) study in five nordic countrie	36
Cost effectiveness of treatment strategies for high risk prostate cancer	36
Evaluation of headache in patients with cancer	36
Making progress against rare cancers: A case study on neuroendocrine tumors	35
von Hippel–Lindau disease integrated care pathway: Centralizing, expanding specialists' theatre, and measuring improvement	35
Reproductive outcomes and reproductive health care utilization among male survivors of childhood cancer: A DCCSS‐LATER study	35
IMMUNOREACT 7: Regular aspirin use is associated with immune surveillance activation in colorectal cancer	35
The prognostic role of mitotic rate in cutaneous malignant melanoma: Evidence from a multicenter study on behalf of the Italian Melanoma Intergroup	35
An ounce of prevention: Medicaid's role in reducing the burden of cancer in men with HIV	34
Industry engagement: Accelerating discovery, application, and adoption through industry partnerships	33
Challenges in clinical trials for high‐risk but curable prostate cancer	33
Fine‐tuning of frontline tyrosine kinase inhibitor (TKI) therapy in chronic‐phase chronic myeloid leukemia: The choice of the right TKI for the right patient	33
Person‐centered communication about weight and weight management: Focus group discussions in a diverse sample of women with nonmetastatic breast cancer and obesity	33
Early‐phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials	32
Circulating tumor DNA in head and neck cancer: Early successes and future promise	32
A real‐world observation on thrombopoietic agents for patients with cancer treatment–induced thrombocytopenia in China: A multicenter, cross‐sectional study	32
Individual‐ and neighborhood‐level socioeconomic status and risk of aggressive breast cancer subtypes in a pooled cohort of women from Kaiser Permanente Northern California	32
Issue Information	31
Durable efficacy with fixed‐duration BTKi and venetoclax for CLL	31
Reassessing the measurement and presence of therapeutic misconception in a phase 1 setting	31
Cell‐free DNA in recurrent and metastatic endometrial cancer: The future is now? Promises and potential pitfalls	31

	31
Adolescent and young adult cancer survivors are at increased risk for a second cancer	31
Fertility preservation before and after cancer treatment in children, adolescents, and young adults	30
	30
Issue Information	30
SMAD4 loss predicts worse overall and distant metastasis‐free survival in patients with resected pancreatic adenocarcinoma	30
Oncologist affects integrative cancer care by writing songs with patients	30
What enhanced recovery means for patients with cancer undergoing surgery	30
	30
Preventive strategies for breast cancer–related lymphedema: Working toward optimal patient selection	30
What if the age at which a woman started regular mammographic screening depended on her risk, not age?	30
Potential of circulating tumor DNA to refine immunotherapy	29
Association of the m6A reader IGF2BP3 with tumor progression and brain‐specific metastasis in breast cancer	29
Associations between racial categories and outcomes suggest structural causes, not genetic advantages	29
	29
Attack of the clones: Unveiling subclonal/heterogenous mismatch repair/microsatellite instability status in endometrial cancer	29
Let's ask the patient: Self‐reported quality‐of‐life measures help to predict kidney cancer mortality	28
The important role of nighttime compression in breast cancer–related lymphedema treatment	28
Gut microbiome linked to aggressive prostate cancer	28
Data‐driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer	28
Pathfinders in oncology from the time the causal relation between tobacco use and lung cancer was established to publication of the first Cancer Staging Manual by the American Joint Committee on Cance	27
Volume standards and outcomes measurement—Complementary strategies to improve surgical quality	27
Issue Information	27
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high‐dose chemotherapy and peripheral blood stem cell transplantation	27
Reply to Air pollution was high centuries before industrial revolutions and may have been responsible for cancer rates in medieval Britain	27
Increasing risk of hepatocellular carcinoma with successive generations in the United States among Mexican American adults: The Multiethnic Cohort	26
Cocooning against COVID‐19: The argument for vaccinating caregivers of patients with cancer	26
Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort stu	26
Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli population	26
Updated American Cancer Society lung cancer screening guidelines	26
FDA approves new combined treatment for advanced prostate cancer	26
Improving colorectal cancer screening by providing options	26
Higher severity and risk of in‐hospital mortality for COVID‐19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary data	26
ASCO releases equity, diversity, and inclusion action plan	26
Pathological and radiological response following neoadjuvant treatments in primary localized resectable myxofibrosarcoma and undifferentiated pleomorphic sarcoma of the extremities and trunk wall	25
Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate‐risk and high‐risk head and neck squamous cell carcinoma	25
The effects of curative‐intent cancer therapy on employment, work ability, and work limitations	25
Prevalence and predictors of cancer‐related worry and associations with health behaviors in adult survivors of childhood cancer	25
Sex‐based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children’s Oncology Group report	24
Transplantation for myeloid neoplasms with antecedent solid tumor	24
Routine estradiol testing recommended for women at high risk of breast cancer	24
Issue Information	24
Anticancer therapies increase thromboembolic risk in hospitalized patients with cancer and COVID‐19	24
Do all patients with cancer experience fatigue? A longitudinal study of fatigue trajectories in women with breast cancer	24
Outcome of Philadelphia chromosome‐positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy—The Surveillance, Epidemiology, and End Results database, 2000–2019	24
Positron emission tomography/computed tomography in the management of Hodgkin and B‐cell non‐Hodgkin lymphoma: An update	24
A phase 2 study of first‐line nivolumab in patients with locally advanced or metastatic cutaneous squamous‐cell carcinoma	24
In pursuit of equity in cancer care: Moving beyond the Affordable Care Act	24
An invisible population: Late‐stage cancer diagnosis for people with intellectual or developmental disability	23
Correlation analyses of radiographic progression‐free survival with clinical and health‐related quality of life outcomes in metastatic castration‐resistant prostate cancer: Analysis of the phase 3 VIS	23
Histologic type predicts disparate outcomes in pediatric hepatocellular neoplasms: A Pediatric Surgical Oncology Research Collaborative study	23
Health insurance literacy among patients receiving outpatient cancer treatment	23
A nomogram for predicting axillary node pathologic complete response—A necessary component of the path toward true axillary de‐escalation but needs a clear definition of the research question and a ro	23
Association between prediagnostic prostate‐specific antigen and prostate cancer probability in Black and non‐Hispanic White men	23
Breast screening participation and degree of spread of invasive breast cancer at diagnosis in mental health service users: A population linkage study	22
The importance of the person/patient/survivor's lived experience across the cancer control continuum	22
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features	22
Critical insights into the evolving drug‐approval process in China	22
Novel biomarker significantly improves diagnostic accuracy for nasopharyngeal cancer	22
New test for detecting cervical adenocarcinoma	22
Thank You to Reviewers 2023	22
Diabetic severity and oncological outcomes of colorectal cancer following curative resection: A population‐based cohort study in Taiwan	22
Training oncology care providers in the assessment and treatment of tobacco use and dependence	21
Evaluating the sustainability of patient navigation programs in oncology by length of existence, funding, and payment model participation	21
Risk‐reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system	21
Chemoimmunotherapy in patients with extensive‐stage small cell lung cancer and a poor performance status	21
Prediction models for breast cancer prognosis among Asian women	21
Children and adolescents with hematologic cancers deserve better end‐of‐life care	21
The American Cancer Society and patient navigation: Past and future perspectives	20
The economics of advanced and unresectable hepatocellular carcinoma	20
MRI is more accurate than a PSMA PET/CT scan for prostate cancer diagnosis	20
Reply to “Micro‐ultrasound may significantly reduce the proportion of unnecessary prostate biopsies in patients with PI‐RADS 3 lesions”	20
Understanding risk factors for cancer: What's new and how can it help reduce the cancer burden?	20
Patients with completely resected nongenitourinary low‐risk embryonal rhabdomyosarcoma are candidates for reduced duration low‐intensity chemotherapy	20
Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer	20
Time to cancer treatment and reproductive outcomes after fertility preservation among adolescent and young adult women with cancer	20
Myeloma, melphalan, and the taste of transplantation	20
Brain–computer interface relieves chronic chemotherapy‐induced peripheral neuropathy: A randomized, double‐blind, placebo‐controlled trial	20
Breast arterial calcification is a risk factor for cardiovascular disease	20
Issue Information	20

Issue Information	20
	20
Role of primary care in opioid prescribing for older head and neck cancer survivors	19
A guide to large data sets for population‐based cancer research: Strengths, limitations, and pitfalls	19
Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients	19
Patient navigation to address sociolegal barriers for patients with cancer: A comparative‐effectiveness study	19
Sharp rise in esophageal cancer and Barrett esophagus seen in middle‐aged people	19
Patients with glioblastoma: A tale of health care access and genetic ancestry	19
Top advances of the year: Cervical cancer	19
Survival difference between secondary and de novo acute myeloid leukemia by age, antecedent cancer types, and chemotherapy receipt	19
Yale study finds Black patients are more likely to experience uterine cancer testing delays	19
	19
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas	19
Family characteristics and childcare patterns associated with early social functioning in cancer‐bereaved parents	19
Top advances of the year: Pediatric oncology	19
SARC‐F to screen or diagnose sarcopenia in cancer? A point‐blank refusal	18
Annual report to the nation on the status of cancer	18
Global cancer statistics 2022	18
Issue Information	18
Issue Information	18
Race‐inclusive and equitable access to immune checkpoint inhibitor therapy: What are the biggest hurdles?	18
Cutaneous β‐HPV may predict cutaneous squamous cell carcinoma	18
Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1	18
Sensitivity of US Preventive Services Task Force and PLCOm2012 lung cancer screening eligibility criteria in individuals with lung cancer in South Dakota self‐reporting as Indigenous and non‐Indigenou	18
Top advances of the year: Myeloproliferative neoplasms	18
FDA center issues new guidelines, approves drugs	18
Estimating the impact of enhanced care at minority‐serving hospitals on disparities in the treatment of breast, prostate, lung, and colon cancers	18
	18
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana	18
Issue Information	18
Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies	18
Antiprogrammed death ligand 1 therapy failed to reduce the risk of developing brain metastases in patients with extensive‐stage small cell lung cancer: A retrospective analysis	17
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor	17
Establishing a health profession: What oncology patient navigators can learn from the National Association of Community Health Workers	17
Symptomatic androgen deficiency and sexual dysfunctions in male patients receiving alectinib for ALK‐positive advanced non–small cell lung cancer	17
Immunotherapy for metastatic non–small cell lung cancer: Is it really a no‐brainer?	17
Adjuvant cyclin‐dependent kinase 4/6 inhibition in hormone receptor–positive breast cancer: One Monarch to rule them all?	17
Evolving concepts in meningioma management in the era of genomics	17
The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival	17
Occupational exposures and risk of nasopharyngeal carcinoma in a high‐risk area: A population‐based case‐control study	17
Implementation, enrollment, and engagement in an opt‐out telehealth pharmacist‐assisted tobacco treatment program for patients seen in oncology outpatient clinics	16
Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer	16
Access to innovation through the national early access program and clinical trials for patients with malignant melanoma	16
Epistemic equity in oncology: Opportunities to leverage patient‐centric implementation in clinical trial design	16
The role of relative advantage for development of sequencing‐based diagnostics for pediatric cancer in low‐ and middle‐income countries	16
Association of polypharmacy and potential drug‐drug interactions with adverse treatment outcomes in older adults with advanced cancer	16
Virtual reality for pain management in hospitalized patients with cancer: A randomized controlled trial	16
Reply to “Metformin as a booster or obstacle of immunotherapy in patients with non–small cell lung cancer and diabetes mellitus”	16
	16
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma	16
Association of the social disorganization index with time to first septic shock event in children with acute myeloid leukemia	16
Assessing trends in breast care surveillance metrics after implementing surgeon‐specific tracking and performance reporting in a large, integrated cancer network	16
Active Living After Cancer: Adaptation and evaluation of a community‐based physical activity program for minority and medically underserved breast cancer survivors	16
Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial	16
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade	16
Immune scoring model based on immune cell infiltration to predict prognosis in diffuse large B‐cell lymphoma	16
Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas	16
	16
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple‐negative breast cancer	16
Certain cancer types show global variation in mortality rates	16
Dispositional hope as a potential outcome parameter among patients with advanced malignancy: An analysis of the ENABLE database	16
Alcohol consumption and prognosis and survival in breast cancer survivors: The Pathways Study	15
Top advances of the year: Pancreatic cancer	15
Evaluating the impact of multicancer early detection testing on health and economic outcomes: Toward a decision modeling strategy	15
Preclinical evaluation and phase 1 study of the PI3Kα/δ inhibitor TQ‐B3525 in Chinese patients with advanced cancers	15
Clinical and genetic risk factors for radiation‐associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort	15
Exemptions to state laws regulating opioid prescribing for patients with cancer‐related pain: A summary	15
Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis	15
Mental health screening and diagnosis in cancer patients: Impact on mortality and suggestion of racial bias	15
MatchMiner open‐source platform matches patients with cancer to precision medicine trials	15
Tobacco use and cancer‐related symptom burden: Analysis of the US Population Assessment of Tobacco and Health Study	15
	15
Variation in second breast cancer risk after primary invasive cancer by time since primary cancer diagnosis and estrogen receptor status	15
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer	15
“To prescribe or not to prescribe, that is the question”: Perspectives on opioid prescribing for chronic, cancer‐related pain from clinicians who treat pain in survivorship	15
Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women’s Health Initiative	15
Redefining the “crown”: Approaching chemotherapy‐induced alopecia among Black patients with breast cancer	15
Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case‐series analysis from the Italian Rare Cancers Network	15
Neoadjuvant immunotherapy is safe before surgery in head and neck squamous cell carcinoma. Is it time to challenge the standard‐of‐care?	15
Issue Information	15
Adherence to hormonal therapy after surgery among older women with ductal carcinoma in situ: Implications for breast cancer–related adverse health events	15
Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies	15
Gastroesophageal reflux disease: A risk factor for laryngeal squamous cell carcinoma and esophageal squamous cell carcinoma in the NIH‐AARP Diet and Health Study cohort	15
Economic distress, financial toxicity, and medical cost‐coping in young adult cancer survivors during the COVID‐19 pandemic: Findings from an online sample	15
Individual prediction of nonadherence to oral mercaptopurine in children with acute lymphoblastic leukemia: Results from COG AALL03N1	14
Chemotherapy with the use of next‐generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults	14
Dual checkpoint inhibition in gallbladder cancer: Bridging new hope with the need for biomarkers	14
Association of physical exercise and a healthy gut microbiome in colorectal cancer	14
Issue Information	14
Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534)	14
Impact of lung cancer screening on stage migration and mortality among the national Veterans Health Administration population with lung cancer	14
Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry	14
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement	14
Population‐specific validation and comparison of the performance of 77‐ and 313‐variant polygenic risk scores for breast cancer risk prediction	14
Optimal timing of radiotherapy after radical prostatectomy points to salvage radiotherapy for PSA failure	14